Literature DB >> 17379529

Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication.

Beatriz Cesar1, Ana Paula R Abud, Carolina C de Oliveira, Francolino Cardoso, Waldemiro Gremski, Juarez Gabardo, Dorly de Freitas Buchi.   

Abstract

Canova is a Brazilian homeopathic medication with immunomodulatory properties, recommended for patients where the immune system is depressed. Previous studies demonstrated that Canova induces up-regulation in numbers of leukocytes. The bone marrow microenvironment is composed of growth factors, stromal cells, extracellular matrix and progenitor cells that differentiate into mature blood cells. We now report the effect of in vitro administration of the medication on the mononuclear differentiation of the bone marrow cell. Swiss mice femurs were dissected cleaned and the cells of the marrow were flushed. The cells were plated, treated or not, incubated for different times and processed for light, transmission and scanning electron, and confocal microscopy analysis. Bone marrow cells showed an enhanced proliferation in vitro in response to Canova medication and Canova plus M-CSF and an increase was also observed in the numbers of the cell niches and ring-shaped nuclei cells. Confocal and transmission and scanning electron microscopy showed the stages of monocyte maturation, with resting and activated cells. With Canova treatment there was a marked increase in cell size, which is mainly attributable to the augmented cytoplasm, an increase in the number of mitochondria, expansion of the RER and an enlarged Golgi. The response to Canova treatment indicates that it influences mononuclear differentiation and activation of bone marrow progenitor and stromal cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379529     DOI: 10.1016/j.micron.2007.02.005

Source DB:  PubMed          Journal:  Micron        ISSN: 0968-4328            Impact factor:   2.251


  6 in total

1.  In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.

Authors:  Fernando S F Guimarães; Lucas F Andrade; Sharon T Martins; Ana P R Abud; Reginaldo V Sene; Carla Wanderer; Inés Tiscornia; Mariela Bollati-Fogolín; Dorly F Buchi; Edvaldo S Trindade
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

2.  Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration.

Authors:  Howard E Gendelman; Shengyuan Ding; Nan Gong; Jianuo Liu; Servio H Ramirez; Yuri Persidsky; R Lee Mosley; Tong Wang; David J Volsky; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-26       Impact factor: 4.147

3.  Experimental gastric carcinogenesis in Cebus apella nonhuman primates.

Authors:  Joana de Fátima Ferreira Borges da Costa; Mariana Ferreira Leal; Tanielly Cristina Raiol Silva; Edilson Ferreira Andrade Junior; Alexandre Pingarilho Rezende; José Augusto Pereira Carneiro Muniz; Antonio Carlos Cunha Lacreta Junior; Paulo Pimentel Assumpção; Danielle Queiroz Calcagno; Samia Demachki; Silvia Helena Barem Rabenhorst; Marília de Arruda Cardoso Smith; Rommel Rodriguez Burbano
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

4.  Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication.

Authors:  Fernando S F Guimarães; Ana P R Abud; Simone M Oliveira; Carolina C Oliveira; Beatriz César; Lucas F Andrade; Lucélia Donatti; Juarez Gabardo; Edvaldo S Trindade; Dorly F Buchi
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

5.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

6.  Reporting experiments in homeopathic basic research (REHBaR)--a detailed guideline for authors.

Authors:  B Stock-Schröer; H Albrecht; L Betti; P C Endler; K Linde; R Lüdtke; F Musial; R van Wijk; C Witt; S Baumgartner
Journal:  Homeopathy       Date:  2009-10       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.